risedronate sodium

Italy

Drugs containing this active substance

  • ACTONEL

    The drug is used for the treatment of osteoporosis in postmenopausal women and, in some formulations, also in men at high risk of fractures. Other versions are indicated for Paget's disease of bone.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: THERAMEX IRELAND LIMITED

  • It is used to treat osteoporosis in postmenopausal women (to reduce the risk of vertebral or hip fractures) and in men at high risk of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: SPA SOCIETA' PRODOTTI ANTIBIOTICI S.P.A.

  • The medicine is used for the treatment of osteoporosis in postmenopausal women and, in some formulations, also for the prevention of osteoporosis or for the treatment of osteoporosis in men at high risk of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: THERAMEX IRELAND LIMITED

  • It is used for the treatment of osteoporosis in postmenopausal women (to reduce the risk of spinal and hip fractures) and in men at high risk of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: GENETIC S.P.A.

  • It is used for the treatment of osteoporosis in postmenopausal women (including in cases of severe osteoporosis) and in men, with the aim of reducing the risk of vertebral and hip fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: DYMALIFE PHARMACEUTICAL S.R.L.

  • It is used for the treatment of osteoporosis in post-menopausal women and in men at high risk of fractures, acting on the bones to make them stronger.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • It is used for the treatment of osteoporosis in postmenopausal women. It acts on the bones to make them stronger and less prone to fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • It is used for the treatment of osteoporosis in both postmenopausal women (to reduce the risk of spinal and hip fractures) and in men at high risk of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: LABORATORI ALTER S.R.L.

  • This medicine is used for the treatment of osteoporosis in postmenopausal women and in men, or for the prevention of osteoporosis in women at risk. Some versions of the drug are also indicated for the treatment of Paget's disease of the bone.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.

  • It is used for the treatment of osteoporosis in postmenopausal women and in men, with the aim of strengthening bones and reducing the risk of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: DOC GENERICI SRL

  • It is used for the treatment of osteoporosis in postmenopausal women, acting directly on the bones to strengthen them and reduce the risk of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: DOC GENERICI SRL

  • This medicine is used for the treatment of osteoporosis (in post-menopausal women and in men) and for the treatment of Paget's disease of the bone.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: EG S.P.A.

  • It is used for the treatment of osteoporosis in postmenopausal women. It acts on the bones to make them stronger and less prone to fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: EG S.P.A.

  • It is used for the treatment of osteoporosis in postmenopausal women and in men. It works by strengthening the bones and reducing the risk of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: MYLAN S.P.A.

  • It is used to treat osteoporosis in postmenopausal women (to reduce the risk of spinal and hip fractures) and in men at high risk of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: SANDOZ S.P.A.

  • It is used for the treatment of osteoporosis in both postmenopausal women and men, with the aim of reducing the risk of vertebral and hip fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: TECNIGEN S.R.L.

  • It is used for the treatment of osteoporosis in both postmenopausal women and men, acting on the bones to make them stronger and less prone to fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: EURO-PHARMA S.R.L.

  • It is used for the treatment of osteoporosis in both postmenopausal women (including in cases of severe osteoporosis) and men, with the aim of reducing the risk of fractures.

    Form: tablets, film-coated

    Active substance Dosage
    risedronate sodium -

    ATC: M05BA07

    Manufacturer: LANOVA FARMACEUTICI S.R.L.